Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
01/2010
01/20/2010EP1513818B1 Heterocyclic inhibitors of vegfr-2 kinases
01/19/2010US7649005 Substituted benzylaminoalkylene heterocycles
01/19/2010US7648999 Activator for peroxisome proliferator-activated receptor δ
01/19/2010CA2413000C Five-membered ring compounds
01/19/2010CA2143135C Process for sulfinylating heterocyclic compounds
01/14/2010WO2010004228A2 Novel discriminating molecule family for neutron and gamma radiation
01/14/2010WO2009140932A3 Method of producing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone
01/14/2010US20100010232 Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives
01/14/2010US20100010227 Process for production of piperidine derivatives
01/14/2010US20100010063 Heterocyclocarboxamide derivatives
01/14/2010US20100010060 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof
01/14/2010US20100009991 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
01/14/2010US20100009978 Benzoxazoles and Oxazolopyridines Being Useful as Janus Kinases Inhibitors
01/14/2010CA2730377A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
01/13/2010EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
01/13/2010CN101627021A Prophylactic and/or therapeutic agent for hyperlipemia
01/12/2010US7645798 N-(2-hydroxyalkanoyl)-N,N′-dialkylureas and a process for their preparation
01/12/2010US7645781 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
01/12/2010US7645779 Linked biaryl compounds
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010US7645751 Mandelic acid derivatives and their use as thrombin inhibitors
01/12/2010CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
01/12/2010CA2375834C Process for making taxane derivatives
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
01/07/2010WO2010002209A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
01/07/2010WO2009000533A8 Novel herbicides
01/07/2010US20100004301 Benzoxazoles Useful in the Treatment of Inflammation
01/07/2010US20100004298 P-38 inhibitors
01/07/2010US20100004297 Novel hexafluoroisopropanol derivatives
01/07/2010US20100004292 Iminooxazolidine Derivatives and Their Use
01/07/2010US20100004277 Compounds and methods for modulating protein trafficking
01/07/2010US20100004271 Heterocyclic compounds as aganist for the thyroid receptor
01/07/2010US20100003445 Cyanine compound and optical filter and optical recording material containing same
01/06/2010EP2141155A1 Prophylactic and/or therapeutic agent for hyperlipemia
01/06/2010EP2141154A1 Oxazolidinone derivative having inhibitory activity on 11 -hydroxysteroid dehydrogenase type i
01/06/2010EP2140865A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
01/06/2010EP2139875A2 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
01/05/2010US7642358 Antidiabetic agents; modulate insulin drug resistance
01/05/2010US7642303 Thermoplastic articles for packaging UV sensitive materials, processes for the articles production and use and novel UV absorbers
01/05/2010CA2318192C .beta.2-adrenergic receptor agonists
12/2009
12/31/2009US20090326020 Compounds for treatment of cancer
12/31/2009US20090325962 Tyrosine derivative
12/31/2009US20090325944 Methods and Compositions for Modulating Glycosylation
12/30/2009WO2009157019A2 Process for preparing ezetimibe using novel allyl intermediates
12/30/2009EP2136637A1 Inhibitors of cholesterol ester transfer protein
12/30/2009EP1613587B1 Organic compounds
12/30/2009EP1501812B1 Pna monomer and precursor
12/30/2009CN101616902A 2-aminooxazolines as TAAR1 ligands
12/30/2009CN100575348C Synthesis of amino acid, n-carboxyanhydrides
12/30/2009CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/29/2009US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
12/29/2009US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists
12/29/2009US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/24/2009US20090318514 Novel Pharmaceutical Compositions
12/24/2009US20090318445 Pdf inhibitors
12/23/2009WO2009154785A2 C4-substituted alpha-keto oxazoles
12/23/2009WO2009153238A1 Aminothiazoline compounds for combating insects, arachnids and nematodes
12/23/2009WO2009066060A3 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use
12/23/2009EP2134697A2 Separation and manipulation of a chiral object
12/23/2009EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
12/23/2009CN100572367C 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes
12/23/2009CN100572348C Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
12/22/2009US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
12/22/2009CA2558908C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives and intermediates useful in the preparation thereof
12/22/2009CA2290744C Cyclic diamine compounds and medicine containing the same
12/17/2009WO2009149508A1 Novel potassium channel blockers and uses thereof
12/17/2009WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/17/2009US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009US20090312363 Bifunctional histone deacetylase inhibitors
12/17/2009US20090312303 Antidiabetic Bicyclic Compounds
12/17/2009US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/17/2009CA2727780A1 Novel potassium channel blockers and uses thereof
12/16/2009EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof
12/16/2009CN101602740A Method for extracting epigoitrin from isatis root with high extraction ratio
12/16/2009CN100569729C Method for producing optically active cyclopropanecarboxylate compound
12/15/2009US7632928 4-oxo-pent-2-enenitrile derivative of a nitrofuran conjugated to a bifunctional cross-linker alone, a bifunctional cross-linker conjugated further to a protein carrier, a peptide conjugated to a protein carrier, and a protein, a nucleic acid, a polysaccharide; antibody and immunogen
12/15/2009US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009CA2342217C Process for producing stereoselective nitro compounds
12/10/2009WO2009101082A9 Substituted sulfonic acid amide compounds
12/10/2009WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009US20090306389 Intermediate products for producing oxazolidinone-quinolone hybrids
12/10/2009US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/09/2009EP2129654A1 Novel antagonists of the glucagon receptor
12/09/2009EP1435964B1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1300401B1 Thiazole derivatives for use as antiinflammatories
12/09/2009EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/09/2009CN101600700A Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders
12/09/2009CN101600689A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/09/2009CN100567277C Production of N-containing pentabasic heteroaromatic formamidine and salts thereof
12/09/2009CN100567273C Organic compounds
12/09/2009CN100567265C Organometallic complexes and organic electroluminescence device using the same
12/08/2009US7629467 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
12/08/2009CA2404725C Extrusion die
12/03/2009US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 210